It is widely considered that if an operating room (OR) is the economic engine for the hospital, then the infection control department is the cost center. No one thinks of this cost center, unless something goes wrong with the surgical facility.
While autoclaves can be used to sterilize surgical instruments, associated equipment such as imaging systems, video processing equipment, lights, tables, carts, and C-arms must be disinfected after each patient contact. With health and environmental concerns about traditional disinfectants growing, there is a market opening for hospital-grade disinfectants that kill bacteria and viruses rapidly, are harmless to humans and equipment, while being environmentally safe.
Additionally, with Hospital-Acquired Infections (HAIs) on the rise, including MRSA, the need to maintain a safe surgical environment has never been more critical. All clinical personnel must constantly monitor their own movements and practices, those of others, and the status of the overall field to prevent inadvertent breaks in the chain of infection. Any breach in procedures to prevent contamination can place the patient and the clinical staff at high risk as well as place tremendous cost burdens on hospitals.
NDS Surgical Imaging is the first company to address cross-contamination risks in medical imaging with innovative infection control solutions that help maintain a safer environment for the patient and clinical teams, increase OR efficiencies and reduce costs associated with HAIs.
« Back Home |
- Hospital sales of disinfectants expected to increase more rapidly (CAGR through 2008 at 2%) than overall antibacterial products, according to Frost & Sullivan
- Total disinfection market, including sanitization, estimated worldwide at $20 billion
- US infection prevention market to approach $9 billion in 2007
- US medical surface disinfection market size estimated at $130 million
|